In this episode Jimmy and Roya are recording straight from AAO 2021 in Boston. They had the great pleasure to talk to Jeff Nau, Ph.D., president and CEO of Oyster Point Pharma, a company who is developing , and delivering innovative therapies for ophthalmic disease.

SOURCES: 

Valley Contax CLIP Program

AAO 2021 Meeting

Jeff Nau PhD: LinkedIn

OysterPoint Tyrvaya-pro